Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism

ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity

(2020) John Alec Moral et al.   NATURE

Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis

(2019) Divya Thomas et al.   Molecular Cancer

Blocking CXCLs–CXCR2 axis in tumor–stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell invasion/migration and a shift of immune-inflammatory microenvironment

(2019) Makoto Sano et al.   Oncogenesis

IL-33trap is a novel IL-33 neutralizing biologic that inhibits allergic airway inflammation

(2019) Aurora Holgado et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts

(2019) Ela Elyada et al.   Cancer Discovery

From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer

(2019) Christopher Nevala-Plagemann et al.   Nature Reviews Clinical Oncology

The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2019) Akram Pourshams et al.   Lancet Gastroenterology & Hepatology

Curation of the Pancreatic Ductal Adenocarcinoma Subset of the Cancer Genome Atlas Is Essential for Accurate Conclusions about Survival-Related Molecular Mechanisms

(2018) Ivana Peran et al.   CLINICAL CANCER RESEARCH

Optimizing the outcomes of pancreatic cancer surgery

(2018) Oliver Strobel et al.   Nature Reviews Clinical Oncology

Targeting macrophages: therapeutic approaches in cancer

(2018) Luca Cassetta et al.   NATURE REVIEWS DRUG DISCOVERY

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

(2018) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes

(2018) Andrew McGuigan et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

(2017) Daniel Öhlund et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Tumour-associated macrophages as treatment targets in oncology

(2017) Alberto Mantovani et al.   Nature Reviews Clinical Oncology

Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production

(2017) Masaki Nakamura et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

EMT and Treatment Resistance in Pancreatic Cancer

(2017) Nicola Gaianigo et al.   Cancers

CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma

(2016) Colin W. Steele et al.   CANCER CELL

Metastatic colonization by circulating tumour cells

(2016) Joan Massagué et al.   NATURE

Pericyte–fibroblast transition promotes tumor growth and metastasis

(2016) Kayoko Hosaka et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanism

(2016) Yunlong Yang et al.   Nature Communications

The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages

(2016) Yunlong Yang et al.   Nature Communications

Targeting inflammation in pancreatic cancer: Clinical translation

(2016) Colin William Steele et al.   World Journal of Gastrointestinal Oncology

Pancreatic Cancer Metastasis: Are we being Pre-EMTed?

(2015) Srustidhar Das et al.   CURRENT PHARMACEUTICAL DESIGN

Metastases of pancreatic adenocarcinoma: A systematic review of literature and a new functional concept

(2015) Marco Cannistrà et al.   International Journal of Surgery

Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling

(2014) Susann Weissmueller et al.   CELL

Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis

(2012) Thomas Jamieson et al.   JOURNAL OF CLINICAL INVESTIGATION

Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma

(2011) Hideaki Ijichi et al.   JOURNAL OF CLINICAL INVESTIGATION

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

(2011) Bin-Zhi Qian et al.   NATURE

Forty-Year Journey of Angiogenesis Translational Research

(2011) Y. Cao et al.   Science Translational Medicine

Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma

(2010) Tine S. Mantoni et al.   CANCER BIOLOGY & THERAPY

Advanced pancreatic carcinoma: current treatment and future challenges

(2010) Anastasios Stathis et al.   Nature Reviews Clinical Oncology

Innate immune responses of primary murine macrophage-lineage cells and RAW 264.7 cells to ligands of Toll-like receptors 2, 3, and 4

(2009) Londa J. Berghaus et al.   COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES

Role of platelet-derived growth factors in physiology and medicine

(2008) J. Andrae et al.   GENES & DEVELOPMENT

The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice

(2008) Allisson Freire Bento et al.   JOURNAL OF LEUKOCYTE BIOLOGY